David Dockrell, Hamish Simpson, Lorna Marson, Marc Vendrell and Neil Carragher from IRR's Centre for Inflammation Research have been named among 57 new Fellows to be elected to the Royal Society of Edinburgh. Image Several Principal Investigators from Centre for Inflammation Research (CIR) have been elected as Fellows of the Royal Society of Edinburgh. They are named on the list of 57 new Fellows, selected for their personal excellence and contribution to their field, which ranges from physics and medicine to law and literature. They join the 1,800 Fellows from around the world who exist as a resource to share knowledge, inform policy and face the most pressing issues in the world today. CIR Director Professor David Dockrell is an infectious disease clinician scientist whose fundamental discoveries relate to infectious diseases, the regulation of inflammatory responses and immunology. He has delineated mechanisms contributing to the pathogenesis of infectious and non-communicable diseases and his work aims to target host responses to improve disease outcomes. Professor Hamish Simpson is Professor of Orthopaedics & Trauma Department of Orthopaedic Surgery at the University of Edinburgh and Consultant Orthopaedic Surgeon in the Department of Orthopaedic Surgery in Edinburgh Royal Infirmary, specialising in limb reconstruction, musculoskeletal infection and paediatric deformity. His research is in stem cells for musculoskeletal repair, musculoskeletal infection, novel cutting methodologies and impaired bone healing. Professor Lorna Marson, is an outstanding leader in surgery and surgical training. Already a Fellow of the Faculty of Surgical Trainers, she is the first woman to be appointed Professor of Transplant Surgery by the University of Edinburgh and the first woman to be elected President of the British Transplant Society, as well as being Chair of the UK Organ Donation and Transplantation Research Network. Professor Marc Vendrell is Chair of Translational Chemistry and Biomedical Imaging, and his team has pioneered the design of activatable fluorophores for high-resolution optical imaging in live cells and tissues. Vendrell currently co-heads the IRR Chemistry Hub as one of the first global hubs for collaborative non-siloed research to catalyse innovation in medical sciences and accelerate translational outputs. Following a research career that spanned across academia (University of Washington, Beatson Institute of Cancer Research) and the pharmaceutical industry (Yamanouchi and AstraZeneca) sectors, Professor Neil Carragher joined the University of Edinburgh in 2010 to establish and innovative drug discovery unit. He is currently Professor of Drug Discovery and leads laboratories at the Institute of Genetics and Cancer and IRR, specializing in cell based screening technologies to expedite the discovery of both novel drugs and drug repurposing opportunities across multiple disease areas. Image Royal Society of Edinburgh announcement This article was published on 2024-07-08
